Hjem › Perifert T-cellelymfom › California
Kliniske studier for Perifert T-cellelymfom i California
8 studier for Perifert T-cellelymfom søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- City of Hope, Duarte
- University of California, Irvine Medical Center - Hematology/Oncology, Orange
- Stanford University School of Medicine, Stanford
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07192471Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- City of Hope National Medical Center, Duarte
- University of California, Irvine, Irvine
- University of California San Francisco, San Francisco
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06561048A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- City of Hope Medical Center, Duarte
- University of California San Diego Medical Center, Moores Cancer Center, La Jolla
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07195916AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, Duarte
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06137144Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
- Children's Hospital Orange County, Orange
- University of California San Francisco, San Francisco
RekruttererTidlig fase 1
Alder 1 til 31 · Alle kjønn · Oppdatert 18. aug. 2026 · NCT03719105To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
- University of California, San Francisco Fresno, Clovis
- University of California, Los Angeles Hem/ Onc Clinical Research Unit, Suite 600, Santa Monica
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT06072131Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- City of Hope Medical Foundation, Duarte
- University of Southern California, Los Angeles
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2025 · NCT04234048Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
- Stanford University, Stanford
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2025 · NCT03964480Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.